RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Raw

Elevance Health, Inc.ELV

Market cap
$81.4B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2024
Net income----------6,0956,0195,971
Net losses on financial instruments-------------445
Gain on sale of business------------201
Equity in net earnings (losses) of other invested assets----------5622931
Depreciation and amortization---------1,1541,3021,6751,393
Deferred income taxes102745931-66127-1,2729181-540326-76-374
Asset Impairment Charges------------103
Share-based compensation136135146169148165170226294283255264191
Receivables, net-1104024181,900431,381226951,0532562,1382,510683
Other invested assets591522-619361483270-1178
Other assets32025934-405-3412862926170283-37-120-824
Policy liabilities-331978-3461,241193322732-1,0591,8263,5282,5972,254-1,840
Unearned income---------202-113-42-113
Accounts payable and other liabilities---------1,978719824-272
Income taxes-----179-194323-32572140-338404
Other, net44143984597165205926-2166-39
Net cash provided by operating activities1,4173,3743,0523,3694,1163,2054,1853,8276,06110,6888,3648,3995,808
Purchases of investments---------19,49218,66924,94617,986
Proceeds from sale of investments---------11,31810,26911,98816,547
Maturities, calls and redemptions from investments3,3221,8911,8371,3191,3141,4191,8481,9382,4374,7414,34410,6202,025
Changes in securities lending collateral--29405546-214-222-624149-254849956301-73
Purchases of subsidiaries, net of cash acquired-0600--639-2,0801,760-1,9763,4766494,809
Proceeds from sales of subsidiaries, net of cash sold------------363
Purchases of property and equipment4515206477156385848001,2081,0771,0211,0871,1521,256
Other, net7631-1083-1271504563120124
Net cash used in investing activities-1,271-942-2,234-975-1,151-514-5,082-1,259-2,792-7,324-9,638-4,560-5,167
Proceeds from long-term borrowings1,0891,0971,2502,7001,227-5,4588352,4732,4843,4623,0717,710
Repayments of long-term borrowings4827051,8021,7302,697-2,8151,6841,1231,9321,0681,8991,650
Proceeds from Short-Term Debt-1001,1002,0502,7602,4005,8359,1207,5909701,3251,365275
Repayments of short-term borrowings-1009502,0502,6202,5005,0009,2508,0351,6701,0501,375135
Changes in securities lending payable--29405546-214-222-624150-254849956302-75
Changes in bank overdrafts-2826410173-24451471-210-169--933-638
Repurchase and retirement of common stock4,3603,0401,6202,9991,516-1,9981,6851,7012,7001,9002,3162,900
Cash dividends-3584484816576847057768189541,1041,2291,508
Proceeds from Stock Plans------------221
Taxes paid through withholding of common stock under employee stock plans------47818412810293109
Other, net---------488-349412
Net cash provided by (used in) financing activities-3,169-2,019-1,718-1,822-2,997-733427-2,241-2,266-2,567423-1,3181,193
Effect of foreign exchange rates on cash and cash equivalents------------14-6
Change in cash and cash equivalents---------804-8612,5071,828